Table 1.
Some clinical characteristics at baseline
| Characteristics | Balance Group (n = 59) | Strength Group (n = 53) | Whole Group (n = 112) |
|---|---|---|---|
| Age, years | 66 ± 13 | 67 ± 14 | 67 ± 13 |
| Male/Female, n (%) | 38 (64)/21 (36) | 38 (72)/15(28) | 76(68)/36(32) |
| Weight, kg | 79 ± 16 | 84 ± 19 | 81 ± 17 |
| Height, m | 1.71 ± 0.09 | 1.72 ± 0.1 | 1.72 ± 0.09 |
| BMI, kg/m2 | 27 ± 4.7 | 28.0 ± 5.2 | 27.4 ± 4.9 |
| mGFR, mL/min/1.73m2 | 22 ± 7 | 23 ± 9 | 23 ± 8 |
| P-creatinine, μmol/L | 242 ± 90 | 251 ± 92 | 247 ± 91 |
| P-urea, mmol/L | 16 ± 5 | 15 ± 5 | 15 ± 5 |
| P-PTH, pmol/L | 11 (9–17) | 10 (7–16) | 11(8–17) |
| P-Albumin, g/L | 37 ± 4 | 38 ± 3 | 37 ± 3 |
| B-Hemoglobin, g/L | 129 ± 14 | 128 ± 14 | 128 ± 14 |
| P-Potassium, mmol/L | 4.3 ± 0.6 | 4.1 ± 0.5 | 4.2 ± 0.5 |
| P-Calcium, mmol/L | 2.3 ± 0.1 | 2.3 ± 0.1 | 2.3 ± 0.1 |
| P-Ca × P, mmol2/L2 | 2.6 ± 0.7 | 2.5 ± 0.5 | 2.6 ± 0.6 |
| P-Phosphate, mmol/L | 1.2 ± 0.2 | 1.1 ± 0.2 | 1.1 ± 0.2 |
| Base excess, mmol /L | −1.2 (−2.3–0.1) | −1.4 (− 3.2–0.0) | −1.2 (− 2.8–0.1) |
| P-CRP, mg/L | 2.9 (1.3–5.9) | 3.5 (1.5–6.9) | 3.1 (1.3–6.1) |
| Medication, n (%) | |||
| Antihypertensive medication | 55(93) | 50(94) | 105(94) |
| Calcium channel blocker | 33((56) | 32(60) | 65(58) |
| Beta blocker | 36(61) | 37(70) | 73(65) |
| RAAS-blocker | 37(63) | 34(64) | 71(63) |
| Central antiadrenergic medication | 8(14) | 5(9) | 13(12) |
| Active vitamin D | 38(64) | 32(60) | 70(62) |
| Phosphate binder | 24(41) | 18(34) | 42(38) |
| Calcimimetic | 1(2) | 1(2) | 2(2) |
| Statin | 33(56) | 28(53) | 61(54) |
| Comorbidity, n (%) | |||
| Malignancy | 8(14) | 8(15) | 16(14) |
| Ischemic heart disease | 11(19) | 11(20) | 22(20) |
| Peripheral vascular disease | 10(17) | 13(25) | 23(21) |
| Left ventricular dysfunction | 8(14) | 3(6) | 11(10) |
| Diabetes mellitus | 13(22) | 17(32) | 30(27) |
| Systemic collagen vascular disease | 5(8) | 5(9) | 10(9) |
| Others (e.g. hypertension) | 43(73) | 40(75) | 83(74) |
Data presented as mean ± SD or median (25th–75th percentile) or n (%)
P Plasma, B Blood, PTH Parathyroid hormone, Ca×P Calcium phosphate product, CRP C-reactive protein, RAAS Renin - angiotensin - aldosterone system